Ryu Seung Jee, Kim Byung-Wook, Kim Boo Gyeong, Kim Ji Hee, Kim Joon Sung, Kim Jin Il, Park Jae-Myung, Oh Jung-Hwan, Kim Tae Ho, Kim Jin-Jo, Park Seung-Man, Park Cho Hyun, Song Kyo Young, Lee Jun Hyun, Kim Sung Geun, Kim Dong Jin, Kim Wook
Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56, Dongsu-ro, Bupyeong-gu, Incheon, 403-720, Republic of Korea.
Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea.
Surg Endosc. 2016 Dec;30(12):5283-5289. doi: 10.1007/s00464-016-4877-y. Epub 2016 Jun 23.
Endoscopic submucosal dissection (ESD) is an alternative to surgical resection for treating early gastric cancer (EGC). However, there have been limited reports on the long-term outcome of ESD compared to that of surgical resection. The aim of this study was to evaluate the immediate and long-term clinical and oncologic outcomes of ESD compared to surgical resection.
We retrospectively reviewed data of patients in five centers who were treated with ESD or surgical resection for EGC within expanded criteria for ESD from 2006 to 2008.
ESD group had significantly shorter procedure times, shorter fasting period, and shorter hospital stay than the surgical resection group. Immediate complications in the surgical resection group were more common compared to those in the ESD group. Five-year cancer recurrence rate of the ESD group was 12.3 % and significantly higher than 2.1 % of the surgical resection group (P = 0.001). Five-year disease-free survival rate of the surgical resection group was 97 %, which was significantly higher than 85 % of the ESD group (P = 0.001). Metachronous lesions were equally found every year during the follow-up period in the ESD group. Five-year overall survival rates were 100 % for both groups.
ESD might be an acceptable and effective treatment for EGC considering overall survival rates with fewer early complication rates and shorter duration of hospital stay compared to surgical resection. However, intensive and persistent endoscopic surveillance should be performed after ESD for early detection of metachronous lesions.
内镜黏膜下剥离术(ESD)是治疗早期胃癌(EGC)的一种手术切除替代方法。然而,与手术切除相比,关于ESD长期疗效的报道有限。本研究的目的是评估与手术切除相比,ESD的近期和长期临床及肿瘤学疗效。
我们回顾性分析了2006年至2008年在五个中心接受ESD或手术切除治疗EGC且符合ESD扩大标准的患者数据。
ESD组的手术时间明显短于手术切除组,禁食期和住院时间也更短。手术切除组的近期并发症比ESD组更常见。ESD组的五年癌症复发率为12.3%,明显高于手术切除组的2.1%(P = 0.001)。手术切除组的五年无病生存率为97%,明显高于ESD组的85%(P = 0.001)。在随访期间,ESD组每年发现的异时性病变数量相同。两组的五年总生存率均为100%。
考虑到总生存率,与手术切除相比,ESD早期并发症较少,住院时间较短,可能是一种可接受且有效的EGC治疗方法。然而,ESD术后应进行强化和持续的内镜监测,以便早期发现异时性病变。